1. Home
  2. GRF vs MLSS Comparison

GRF vs MLSS Comparison

Compare GRF & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eagle Capital Growth Fund Inc.

GRF

Eagle Capital Growth Fund Inc.

N/A

Current Price

$10.08

Market Cap

39.9M

Sector

Finance

ML Signal

N/A

Logo Milestone Scientific Inc.

MLSS

Milestone Scientific Inc.

HOLD

Current Price

$0.40

Market Cap

35.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRF
MLSS
Founded
1989
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Industrial Specialties
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.9M
35.3M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
GRF
MLSS
Price
$10.08
$0.40
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$1.00
AVG Volume (30 Days)
2.3K
106.1K
Earning Date
01-01-0001
05-14-2026
Dividend Yield
3.70%
N/A
EPS Growth
N/A
N/A
EPS
1.16
N/A
Revenue
N/A
$8,973,982.00
Revenue This Year
N/A
$12.64
Revenue Next Year
N/A
$8.99
P/E Ratio
$8.69
N/A
Revenue Growth
N/A
3.99
52 Week Low
$9.60
$0.22
52 Week High
$11.85
$0.68

Technical Indicators

Market Signals
Indicator
GRF
MLSS
Relative Strength Index (RSI) 45.99 52.15
Support Level $9.96 $0.24
Resistance Level $10.57 $0.40
Average True Range (ATR) 0.06 0.04
MACD 0.01 -0.00
Stochastic Oscillator 17.78 33.75

Price Performance

Historical Comparison
GRF
MLSS

About GRF Eagle Capital Growth Fund Inc.

Eagle Capital Growth Fund Inc is a diversified closed-end investment company. The Fund's objective is long-term growth utilizing the concept of total return for selecting investments. It seeks to achieve its investment objectives by investing predominantly in U.S. issuer common stock, giving preference to high-quality companies, where high quality denotes substantial operating income margins, high returns on capital, and robust balance sheets.

About MLSS Milestone Scientific Inc.

Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.

Share on Social Networks: